Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neoplasm Metastasis × Folfox protocol × Clear all

Phase

Phase 2 9 Phase 3 5 Phase 1 4 Phase 1/2 2 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 4 Postoperative Complications 1 Neoplasm Metastasis 1 Colonic Neoplasms 1 Cholangiocarcinoma 1

Interventions

Zoledronic Acid 3 Bevacizumab 3 exemestane 2 Therapeutics 2 Oxaliplatin 2 Misoprostol 2 Magnetic Resonance Spectroscopy 2 Letrozole 2 Ibandronic Acid 2 Fluorouracil 2 Cetuximab 2 Capecitabine 2 vandetanib 1 palbociclib 1 liposomal doxorubicin 1 huaier 1 eribulin 1 enzalutamide 1 darolutamide 1 cabozantinib 1 aldesleukin 1 Vindesine 1 Trastuzumab 1 Sugars 1 Stents 1 Standard of Care 1 Sorafenib 1 Radiosurgery 1 Platinum 1 Pharmaceutical Preparations 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02015923 2021-03-16

CCRe-IV

Hospital Universitari de Bellvitge

Phase 4 Terminated

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡